Tenaya Therapeutics

Tenaya Therapeutics

Biotechnology
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.

$73.6M

Market Cap • 11/17/2026

2016

(10 years)

Founded

2021

(5 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

1,3

P/S

—

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

0,2

EPS

—

Market Cap

Market Cap

73,6M

EV

9,6M

EV/Revenue

—

EV/EBITDA

-0,1

EV/EBIT

-0,1

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-89,1%

Total Yield

-89,1%

Payout

0%

Retained Earnings

-686,6M

Profitability

Gross Margin

—

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

0%

Capex/Revenue

0%

Capex/D&A

4,2%

Capex/OCF

-0,4%

SBC/OCF

—

% PPE

4,7%

% Goodwill

0%

ROE

—

ROIC

—

Growth

CAGR Op. Income 5Y

12,9%

CAGR Net Income 5Y

12,3%

CAGR EPS 5Y

-57,6%

CAGR OCF 5Y

-0,2%

Leverage

N.D./EBITDA

0,6

Debt/Equity

0%

Current Ratio

3,8

Quick Ratio

3,6

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium